Strategic investor and operating executive focused on growth-stage consumer and fintech companies. Marilou Davido brings operating leadership across product, go-to-market and partnerships, with experience scaling teams, raising institutional capital and managing M&A processes. Known for data-driven commercial strategy and board-level governance, she often advises founders on customer acquisition and unit economics. Active in seed to Series B rounds and corporate venture initiatives, she combines hands-on operating skills with investor relations experience.
Strategic investor and operating executive focused on growth-stage consumer and fintech companies. Marilou Davido brings operating leadership across product, go-to-market and partnerships, with experience scaling teams, raising institutional capital and managing M&A processes. Known for data-driven commercial strategy and board-level governance, she often advises founders on customer acquisition and unit economics. Active in seed to Series B rounds and corporate venture initiatives, she combines hands-on operating skills with investor relations experience.
Focused on growth-stage consumer and fintech deals, she blends hands-on operating instincts with early-stage investing, targeting seed to Series B opportunities where product-market fit is clear and unit economics can scale. Investment selection emphasizes data-driven customer acquisition, partnership-led distribution, and repeatable revenue models. Capital allocation favors concentrated small bets with reserve for follow-ons, active board or adviser roles, and a 3–7 year horizon to drive commercialization, margin expansion and exit through strategic sale or growth equity rounds.
Focused on growth-stage consumer and fintech deals, she blends hands-on operating instincts with early-stage investing, targeting seed to Series B opportunities where product-market fit is clear and unit economics can scale. Investment selection emphasizes data-driven customer acquisition, partnership-led distribution, and repeatable revenue models. Capital allocation favors concentrated small bets with reserve for follow-ons, active board or adviser roles, and a 3–7 year horizon to drive commercialization, margin expansion and exit through strategic sale or growth equity rounds.
| Trades 2458 | Longs Won 1669/2458 67% | Profit Factor 8.83 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $233,825.9 |
| Average Win $50,129.02 | Best Trade (Aug 14) $5.49M | Sharpe Ratio -10.77 |
| Average Loss -$12,007.56 | Worst Trade (Dec 31) -$1.54M | Z-Score 25.09 (100%) |
| Commissions $0 | Avg. Trade Length 2y 1m 1w 4d | Expectancy $30,183.64 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,857 | 16,071 | 14,286 | 12,500 | 10,714 | 8,929 | 7,143 | 5,357 | 3,571 | 1,786 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 34,161 | $6.16M | $10.55M | - | $4.39M | 71.3% | -7.354% |
ABBV AbbVie Inc. | 7,003 | $972,123.58 | $1.76M | - | $785,209.24 | 80.77% | -2.513% |
ABT Abbott Laboratories | 1,524 | $209,418.51 | $161,086.8 | - | -$48,331.71 | -23.08% | +0.085% |
ACB Aurora Cannabis Inc. | 7 | $31 | $19.53 | - | -$11.47 | -37% | -1.413% |
ACWV iShares MSCI Global Minimum Volatility ETF | 58,709 | $6.28M | $7.31M | - | $1.03M | 16.41% | -0.328% |
AEE Ameren Corporation | 107 | $9,448.38 | $11,728.27 | - | $2,279.89 | 24.13% | +0.791% |
AEP American Electric Power Company, Inc. | 869 | $77,508.19 | $111,101.65 | - | $33,593.46 | 43.34% | +0.055% |
AIZ Assurant Inc. | 2,251 | $423,729 | $628,456.69 | - | $204,727.69 | 48.32% | -1.158% |
ALNY Alnylam Pharmaceuticals Inc | 14 | $2,375 | $2,877.28 | - | $502.28 | 21.15% | +0.019% |
AMAT Applied Materials, Inc. | 5,209 | $818,289.11 | $2.64M | - | $1.83M | 223.17% | +1.176% |
AMD Advanced Micro Devices, Inc. | 30 | $4,317 | $14,284.5 | - | $9,967.5 | 230.89% | -1.904% |
AMGN Amgen Inc. | 71 | $16,197.42 | $27,346.36 | - | $11,148.94 | 68.83% | -0.64% |
AMT American Tower Corporation | 68 | $19,339.29 | $11,788.48 | - | -$7,550.81 | -39.04% | -0.631% |
AMZN Amazon.com Inc | 8,360 | $1.36M | $2.27M | - | $905,976.78 | 66.4% | +15.321% |
ARAY Accuray Incorporated | 181 | $864 | $48.87 | - | -$815.13 | -94.34% | -6.897% |
ATI ATI Inc. | 800 | $31,568 | $149,952 | - | $118,384 | 375.01% | +3.046% |
AVGO Broadcom Inc. | 2,120 | $653,342.01 | $825,273.6 | - | $171,931.59 | 26.32% | +0.371% |
AXP American Express Company | 162 | $37,411.52 | $54,472.5 | - | $17,060.98 | 45.6% | -0.376% |
BA Boeing Company | 105 | $18,585 | $22,694.7 | - | $4,109.7 | 22.11% | -2.155% |
BAC Bank of America Corporation | 4,636 | $184,711.07 | $287,200.2 | - | $102,489.13 | 55.49% | +0.356% |